Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma.

Papadopoulos, K P; Noguera-Irizarry, W; Wiebe, L; Hesdorffer, C S; Garvin, J; Nichols, G L; Vahdat, L H; Lo, K M S; Skerrett, D; Bernstein, D; Sharpe, E; Savage, D G

Papadopoulos, K P; Noguera-Irizarry, W; Wiebe, L; Hesdorffer, C S; Garvin, J; Nichols, G L; Vahdat, L H; Lo, K M S; Skerrett, D; Bernstein, D; Sharpe, E; Savage, D G.

Affiliation

Papadopoulos KP; Institute for Drug Development, San Antonio, TX, USA.

Bone Marrow Transplant ; 36(6): 491-7, 2005 Sep.

Article in En | MEDLINE | ID: mdl-16044139

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Hematopoietic Stem Cell Transplantation/methods; Lymphoma/therapy; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/toxicity; Female; Hematopoietic Stem Cell Transplantation/mortality; Humans; Lymphoma/complications; Lymphoma/mortality; Male; Maximum Tolerated Dose; Melphalan/administration & dosage; Middle Aged; Mitoxantrone/administration & dosage; Pilot Projects; Risk; Survival Analysis; Transplantation Conditioning/methods; Transplantation, Autologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Lymphoma Type of study: Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2005 Document type: Article

Search on Google

XML

PubMed Links